AstraZeneca Seroquel Sales Soar in 2021 as Revenue Peaks

AstraZeneca's financial performance has been notably punctuated by the success of Seroquel, its flagship product, securing a top revenue spot in 2021 with impressive growth outlined in their recent report. This shift underscores pivotal dynamics within the pharmaceutical industry, as AstraZeneca navigates through acquisitions, legal settlements, and expands its sustainability strategies under new leadership.